Email Notification
Receive Daily Availability Emails
Sign Up| Pack NDC# | Product | Strength | Supplied As | Shelf Pack | Inventory |
|---|---|---|---|---|---|
Pack NDC#
0517-6710-10
|
10% Calcium Chloride Injection, USP |
1 Gram (100 mg/mL) |
10 mL |
10 | In Stock |
Pack NDC#
0517-7604-25
|
Acetylcysteine Solution, USP |
20% |
4 mL vial |
25 | In Stock |
Pack NDC#
0517-7504-25
|
Acetylcysteine Solution, USP |
10% |
4 mL vial |
25 | In Stock |
Pack NDC#
0517-9120-25
|
Aminocaproic Acid Injection, USP |
250 mg/mL |
20 mL |
25 | In Stock |
Pack NDC#
0517-9191-25
|
Aminocaproic Acid Injection, USP |
250 mg/mL |
20 mL |
25 | In Stock |
Pack NDC#
0517-1004-25
|
Atropine Sulfate Injection, USP (FDA-Approved) |
0.4 mg/mL |
1 mL |
25 | In Stock |
Pack NDC#
0517-1001-25
|
Atropine Sulfate Injection, USP (FDA-Approved) |
1 mg/mL |
1 mL |
25 | In Stock |
Pack NDC#
0517-0720-01
|
Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP |
6 mg/mL |
5 mL |
1 | Limited Availability |
Pack NDC#
0517-0791-01
|
Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP |
6 mg/mL |
5 mL |
1 | Out of Stock |
Pack NDC#
0517-0799-01
|
Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP |
6 mg/mL |
5 mL |
1 | Limited Availability |
Pack NDC#
0517-2502-10
|
Caffeine and Sodium Benzoate Injection, USP† †Drug is Not FDA Approved |
250 mg/mL |
2 mL |
10 | In Stock |
Pack NDC#
0517-1820-01
|
Chlorothiazide Sodium For Injection, USP |
500 mg |
Single Dose Vial |
1 | In Stock |
Pack NDC#
0517-0031-25
|
Cyanocobalamin (B12) Injection, USP |
1000 mcg/mL |
1 mL |
25 | In Stock |
Pack NDC#
0517-0130-01
|
Cyanocobalamin (B12) Injection, USP |
1000 mcg/mL |
30 mL |
1 | In Stock |
Pack NDC#
0517-0032-25
|
Cyanocobalamin (B12) Injection, USP |
1000 mcg/mL |
10 mL |
25 | Limited Supply |
Pack NDC#
0517-1980-05
|
Dicyclomine Hydrochloride Injection, USP |
20 mg/2 mL |
2 mL |
5 | In Stock |
Pack NDC#
0517-9702-25
|
Droperidol Injection, USP |
5 mg/2 mL |
2 mL |
25 | In Stock |
Pack NDC#
0517-1171-10
|
Epinephrine Injection, USP |
1 mg/mL |
1 mL single-dose ampule |
10 | Out of Stock |
Pack NDC#
0517-0420-01
|
Estradiol Valerate Injection, USP |
20 mg/mL |
5 mL |
1 | In Stock |
Pack NDC#
0517-0440-01
|
Estradiol Valerate Injection, USP |
40 mg/mL |
5 mL |
1 | In Stock |
Pack NDC#
0517-0710-01
|
Fomepizole Injection |
1 g/mL |
1.5 mL |
1 | In Stock |
Pack NDC#
0517-4605-25
|
Glycopyrrolate Injection, USP |
0.2 mg/mL |
5 mL |
25 | In Stock |
Pack NDC#
0517-4620-25
|
Glycopyrrolate Injection, USP |
0.2 mg/mL |
20 mL |
25 | In Stock |
Pack NDC#
0517-4601-25
|
Glycopyrrolate Injection, USP |
0.2 mg/mL |
1 mL |
25 | In Stock |
Pack NDC#
0517-4602-25
|
Glycopyrrolate Injection, USP |
0.2 mg/mL |
2 mL |
25 | In Stock |
Pack NDC#
0517-0901-25
|
HydrALAZINE Hydrochloride Injection, USP |
20 mg/mL |
1 mL Single Dose Vial |
25 | In Stock |
Pack NDC#
0517-4201-25
|
Hydroxyzine HCl Injection, USP |
25 mg/mL |
1 mL |
25 | In Stock |
Pack NDC#
0517-5602-25
|
Hydroxyzine HCl Injection, USP |
50 mg/mL |
2 mL |
25 | In Stock |
Pack NDC#
0517-5601-25
|
Hydroxyzine HCl Injection, USP |
50 mg/mL |
1 mL |
25 | In Stock |
Pack NDC#
0517-0650-01
|
Injectafer® (ferric carboxymaltose injection) |
750 mg iron/15 mL |
15 mL |
1 | In Stock |
Pack NDC#
0517-0602-01
|
Injectafer® (ferric carboxymaltose injection) |
100 mg iron/2 mL |
2 mL |
1 | In Stock |
Pack NDC#
0517-1045-05
|
Levocarnitine Injection, USP |
1 gram/5 mL |
5 mL |
5 | In Stock |
Pack NDC#
0517-1075-01
|
Levocarnitine Injection, USP |
4 grams/20 mL |
20 mL |
1 | In Stock |
Pack NDC#
0517-0740-20
|
Methylergonovine Maleate Injection, USP |
0.2 mg/mL |
1 mL |
20 | In Stock |
Pack NDC#
0517-9302-25
|
Multrys® (trace elements injection 4*, USP)
*Each mL contains zinc 1,000 mcg, copper 60 mcg, |
* |
1 mL |
25 | In Stock |
Pack NDC#
0517-0735-10
|
niCARdipine Hydrochloride Injection, USP |
2.5 mg/mL |
10 mL |
10 | In Stock |
Pack NDC#
0517-4810-25
|
Nitroglycerin Injection, USP |
5 mg/mL |
10 mL |
25 | Limited Availability |
Pack NDC#
0517-0955-01
|
Olanzapine For Injection |
10 mg/Vial |
Single Use Vial |
1 | Limited Availability |
Pack NDC#
0517-4300-01
|
Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin bound) |
100 mg/vial |
Single Dose Vial |
1 | In Stock |
Pack NDC#
0517-4002-25
|
Papaverine HCl Injection, USP† †Drug is Not FDA Approved |
30 mg/mL |
2 mL |
25 | In Stock |
Pack NDC#
0517-0374-05
|
ProvayBlue® (methylene blue) Injection, USP |
50 mg/10 mL |
10 mL |
5 | In Stock |
Pack NDC#
0517-0381-05
|
ProvayBlue® (methylene blue) Injection, USP |
50 mg/10 mL |
10 mL |
5 | In Stock |
Pack NDC#
0517-6560-05
|
Selenious Acid Injection, USP |
600 mcg/10 mL |
10 mL |
5 | In Stock |
Pack NDC#
0517-6502-10
|
Selenious Acid Injection, USP |
12 mcg/2 mL |
2 mL |
10 | In Stock |
Pack NDC#
0517-3010-25
|
Sterile Water For Injection, USP† †Drug is Not FDA Approved |
— |
10 mL |
25 | Out of Stock |
Pack NDC#
0517-3020-25
|
Sterile Water For Injection, USP† †Drug is Not FDA Approved |
— |
20 mL |
25 | In Stock |
Pack NDC#
0517-9305-25
|
Tralement® (trace elements injection 4*, USP)
*Each mL contains zinc 3 mg, copper 0.3 mg, |
* |
1 mL |
25 | In Stock |
Pack NDC#
0517-1020-25
|
Vasopressin Injection, USP |
20 Units/mL |
1 mL |
25 | Limited Availability |
Pack NDC#
0517-1030-01
|
Vasopressin Injection, USP |
20 Units/mL |
10 mL |
1 | In Stock |
Pack NDC#
0517-2310-05
|
Venofer® iron sucrose injection, USP |
200 mg/10 mL |
10 mL |
5 | In Stock |
Pack NDC#
0517-2325-10
|
Venofer® iron sucrose injection, USP |
50 mg/2.5 mL |
2.5 mL |
10 | In Stock |
Pack NDC#
0517-2340-10
|
Venofer® iron sucrose injection, USP |
100 mg/5 mL |
5 mL |
10 | In Stock |
Pack NDC#
0517-2340-25
|
Venofer® iron sucrose injection, USP |
100 mg/5 mL |
5 mL |
25 | In Stock |
Pack NDC#
0517-6103-25
|
Zinc Sulfate Injection, USP |
3 mg/mL |
10 mL |
25 | In Stock |
Pack NDC#
0517-8005-25
|
Zinc Sulfate Injection, USP |
5 mg/mL |
5 mL |
25 | In Stock |
Pack NDC#
0517-6101-25
|
Zinc Sulfate Injection, USP |
1 mg/mL |
10 mL |
25 | In Stock |
FIND OUT FIRST
Receive daily availability emails
News Center
American Regent Announces Results from Phase 3 HEART-FID Trial with INJECTAFER®
Shirley, NY–August 26, 2023: American Regent, Inc., a Daiichi Sankyo Group company, today announced results from the phase 3 HEART-FID trial of INJECTAFER (ferric carboxymaltose injection) for the treatment of iron deficiency in adult heart failure patients with reduced ejection fraction (HFrEF).
INJECTAFER® Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure
Basking Ridge, NJ and Shirley, NY – June 5, 2023: Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) approved INJECTAFER® (ferric carboxymaltose injection) for the treatment of iron deficiency in adult patients with heart failure categorized as New York Heart Association class II/III to improve exercise capacity.
St. John’s University and American Regent Post-Doctoral Pharmaceutical Industry Fellowship Now Recruiting
Melville, NY – September 14, 2023:
Learn more about the St. John’s University and American Regent Post-Doctoral Pharmaceutical Industry Fellowship by downloading our brochure. Information on how to apply to our program as well as key deadlines are included.